Physician profile
Zehra Hooda
NPI 1487097523
$5,717.18
in general payments reported to CMS, 2019-2025
34 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $362 · 2021: $377 · 2022: $498 · 2023: $389 · 2024: $1,562 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,521.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $826.07 | 2019-2021 | |
| Nevro Corp. | $809.20 | 2024 | Senza |
| Globus Medical, INC. | $568.93 | 2025 | Senza, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $438.26 | 2024-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $392.77 | 2023-2025 | Intellis Adaptivestim, Synchromedii |
| Horizon Therapeutics Plc | $338.91 | 2019-2022 | |
| Abbvie INC. | $299.69 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $288.99 | 2019-2024 | Euflexxa |
| Scilex Pharmaceuticals INC. | $216.24 | 2019-2025 | Ztlido |
| Azurity Pharmaceuticals, INC. | $167.43 | 2024-2025 | Horizant |
| Bioventus LLC | $152.69 | 2019-2023 | Durolane, Supartz Fx Sodium Hyaluronate |
| Sanofi-Aventis U.S. LLC | $133.05 | 2019-2022 | |
| Abbott Laboratories | $129.49 | 2019-2024 | Eterna |
| Pacira Pharmaceuticals Incorporated | $108.96 | 2022-2023 | Exparel, Iovera, Zilretta |
| Boston Scientific Corporation | $106.89 | 2019-2025 | General - Pain Management |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $103.37 | 2024-2025 | Qutenza |
| Nalu Medical, INC. | $93.93 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.72 | 2024-2025 | Relistor |
| Fidia Pharma USA INC. | $49.35 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $48.57 | 2022 | |
| Pfizer INC. | $48.09 | 2024 | |
| Kaleo, INC. | $40.27 | 2019 | |
| Lilly USA, LLC | $37.44 | 2024 | Emgality |
| Painteq LLC | $29.76 | 2024 | Painteq |
| Depuy Synthes Sales INC. | $28.07 | 2019-2025 | Orthovisc, Monovisc |
| Biotronik Nro, INC. | $28.04 | 2025 | Prospera |
| Biotissue Holdings INC. | $21.82 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.11 | 2025 | |
| Curonix LLC | $19.99 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $19.60 | 2020 | |
| Assertio Therapeutics, INC. | $14.98 | 2020 | |
| Medinc of Texas | $14.82 | 2023 | |
| Impel Pharmaceuticals LLC | $13.63 | 2025 | Trudhesa |
| Zyla Life Sciences, INC. | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zehra Hooda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.